Biomembrane-permeable and ribonuclease-resistant siRNA with enhanced activity

Oligonucleotides

Volumn 15, Issue 3, 2005, Pages 196-205

  Liao, Hongtao ^a   Wang, Jui H ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLY 2' O (2,4 DINITROPHENYL) SMALL INTERFERING RNA; RIBONUCLEASE; SMALL INTERFERING RNA; SOMATOMEDIN RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL TYPE; CONTROLLED STUDY; DEGRADATION KINETICS; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYDROLYSIS; MEMBRANE PERMEABILITY; MOLECULAR STABILITY; PRIORITY JOURNAL; RNA ANALYSIS; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; TRANSPORT KINETICS; WESTERN BLOTTING;

2,4-DINITROPHENOL; BASE SEQUENCE; BIOLOGICAL TRANSPORT; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; DIFFUSION; HUMANS; HYDROLYSIS; IN SITU HYBRIDIZATION; LIPID METABOLISM; LIPIDS; MOLECULAR SEQUENCE DATA; MUTATION; OLIGONUCLEOTIDES, ANTISENSE; POLYMERS; RECEPTORS, SOMATOMEDIN; RIBONUCLEASES; RNA, DOUBLE-STRANDED; RNA, SMALL INTERFERING; TIME FACTORS;

MAMMALIA;

EID: 25844481481     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2005.15.196     Document Type: Article

References (42)

1. AGRAWAL, N., DASARADHI, P.V., MOHMMED, A., MALHOTRA, P., BHATNAGAR, R.K., and MUKHERJEE, S.K. (2003). RNA interference: Biology, mechanism, and applications. Microbiol. Mol. Biol. Rev. 67, 657-685.
2. ASHUN, M.A., HU, Y., KANG, I., LI, C.C., and WANG, J.H. (1996). Inhibition of murine leukemia virus with poly-2′-O-(2,4-dinitrophenyl) poly[A]. Antimicrob. Agents Chemother. 40, 2311-2317.
3. BASERGA, R. (1999). The IGF-I receptor in cancer research. Exp. Cell Res. 253, 1-6.
4. BASERGA, R., HONGO, A., RUBINI, M., PRISCO, M., and VALENTINIS, B. (1997). The IGF-I receptor in cell growth, transformation and apoptosis. Biochim. Biophys. Acta 1332, 105-126.
5. BASERGA, R., PERUZZI, F., and REISS, K. (2003). The IGF-I receptor in cancer biology. Int. J. Cancer 107, 873-877.
6. BASS, B.L. (2000). Double-stranded RNA as a template for gene silencing. Cell 101, 235-238.
7. BHAUMICK, B., BALA, R.M., and HOLLENBERG, M.D. (1981). Somatomedin receptor of human placenta: Solubilization, photolabeling, partial purification, and comparison with insulin receptor. Proc. Natl. Acad. Sci. USA 78, 4279-4283.
8. BLAKESLEY, V.A., BUTLER, A.A., KOVAL, A.P., OKUBO, Y., and LEROITH, D. (1999). IGF-I receptor function: Transducing the IGF-I signal into intracellular events. In: The IGF System. R.G. Rosenfeld and C.T. Roberts, Jr., eds. (Humana Press, Totowa, NJ), pp. 143-163.
9. BOHULA, E.A., SALISBURY, A.J., SOHAIL, M., PLAYFORD, M.P., RIEDEMANN, J., SOUTHERN, E.M., and MACAULAY, V.M. (2003). The efficacy of small interfering RNAs targeted to the type I insulin-like growth factor receptor (IGF-IR) is influenced by secondary structure in the IGF-IR transcript. J. Biol. Chem. 278, 15991-15997.
10. CARTHEW, R.W. (2001). Gene silencing by double-stranded RNA. Curr. Opin. Cell Biol. 13, 244-248.
11. CHEN, X., SHEN, L., and WANG, J.H. (2004). Poly-2′-DNP-RNAs with enhanced efficacy for inhibiting cancer cell growth. Oligonucleotides 14, 90-99.
12. CHERNAUSEK, S.D., JACOBS, S., and VAN WYK, J.J. (1981). Structural similarities between human receptors for somatomedin C and insulin: Analysis by affinity labeling. Biochemistry 20, 7345-7350.
13. COGONI, C., and MACINO, G. (2000). Post-transcriptional gene silencing across kingdoms. Curr. Opin. Genet. Dev. 10, 638-643.
14. DEVROE, E., and SILVER, P.A. (2002). Retrovirus-delivered siRNA. BMC Biotechnol. 2, 15-19.
15. ELBASHIR, S.M., HARBORTH, J., LENDECKEL, W., YALCIN, A., WEBER, K., and TUSCHL, T. (2001a). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498.
16. ELBASHIR, S.M., HARBORTH, J., WEBER, K., and TUSCHL, T. (2002). Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26, 199-213.
17. ELBASHIR, S.M., MARTINEZ, J., PATKANIOWSKA, A., LENDECKEL, W., and TUSCHL, T. (2001b). Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J. 20, 6877-6888.
18. FIRE, A. (1999). RNA-triggered gene silencing. Trends Genet. 15, 358-363.
19. GALVAN, V., LOGVINOVA, A., SPERANDIO, S., ICHIJO, H., and BREDESEN, D.E. (2003). Type I insulin-like growth factor receptor (IGF-IR) signaling inhibits apoptosis signal-regulating kinase 1 (ASK1). J. Biol. Chem. 278, 13325-13332.
20. GIRNITA, A., GIRNITA, L., DEL PRETE, F., BARTOLAZZI, A., LARSSON, O., and AXELSON, M. (2004). Cyclolignans as inhibitors of the insulin-like growth factor-I receptor and malignant cell growth. Cancer Res. 64, 236-242.
21. GRUNWELLER, A., WYSZKO, E., BIEBER, B., JAHNEL, R., ERDMANN, V.A., and KURRECK, J. (2003). Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2′-O-methyl RNA, phosphorothioates and small interfering RNA. Nucleic Acids Res. 31, 3185-3193.
22. HAMMOND, S.M., CAUDY, A.A., and HANNON, G.J. (2001). Post-transcriptional gene silencing by double-stranded RNA. Nature Rev. Gen. 2, 110-119.
23. JACOBS, S., KULL, F.C., JR., and CUATRECASAS, P. (1983). Monensin blocks the maturation of receptors for insulin and somatomedin C: Identification of receptor precursors. Proc. Natl. Acad. Sci. USA 80, 1228-1231.
24. KULL, F.C., Jr., JACOBS, S., SU, Y.F., SVOBODA, M.E., VAN WYK, J.J., and CUATRECASAS, P. (1983). Monoclonal antibodies to receptors for insulin and somatomedin-C. J. Biol. Chem. 258, 6561-6566.
25. LASSUS, P., RODRIGUEZ, J., and LAZEBNIK, Y. (2002). Confirming specificity of RNAi in mammalian cells. Science's Stke [Electronic Resource]: Signal Transduction Knowledge Environment 147, 13-22.
26. MARTINEZ, J., PATKANIOWSKA, A., URLAUB, H., LUHRMANN, R., and TUSCHL, T. (2002). Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 110, 563-574.
27. MASSAGUE, J., and CZECH, M.P. (1982). The subunit structures of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor. J. Biol. Chem. 257, 5038-5045.
28. MILLIGAN, J.F., GROEBE, D.R., WITHERELL, G.W., and UHLENBECK, O.C. (1987). Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates. Nucleic Acids Res. 15, 8783-8798.
29. RAHMAN, M.H., KANG, I., WATERBURY, R.G., NARANG, U., BRIGHT, F.V., and WANG, J.H. (1996). Selective removal of ribonucleases from solution with covalently anchored macromolecular inhibitor. Anal. Chem. 68, 134-138.
30. RECHLER, M.M., and NISSLEY, S.P. (1985). The nature and regulation of the receptors for insulin-like growth factors. Annu. Rev. Physiol. 47, 425-442.
31. RESNICOFF, M., SELL, C., RUBINI, M., COPPOLA, D., AMBROSE, D., BASERGA, R., and RUBIN, R. (1994). Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-I (IGF-I) receptor are nontumorigenic and induce regression of wild-type tumors. Cancer Res. 54, 2218-2222.
32. RU, K., SCHMITT, S., JAMES, W.I., and WANG, J.H. (1999). Growth inhibition and antimetastatic effect of antisense poly-DNP-RNA on human breast cancer cells. Oncol. Res. 11, 505-512.
33. RU, K., TAUB, M.L., and WANG, J.H. (1998). Specific inhibition of breast cancer cells by antisense poly-DNP-oligoribonucleotides and targeted apoptosis. Oncol. Res. 10, 389-397.
34. SHARP, P.A. (2001). RNA interference-2001. Genes Dev. 15, 485-490.
35. SHEN, L., CHEN, X., and WANG, J.H. (2003). A high-efficacy antisense RIalpha poly-DNP 21-nt RNA. Antisense Nucleic Acid Drug Dev. 13, 67-74.
36. SHEN, L., ZHANG, C., AMBRUS, J.L., Jr., and WANG, J.H. (2005). Silencing of human c-myc oncogene expression by poly-DNP-RNA. Oligonucleotides 15, 23-35.
37. TUSCHL, T. (2001). RNA interference and small interfering RNAs. Chembiochem 2, 239-245.
38. VOINNET, O. (2001). RNA silencing as a plant immune system against viruses [Review]. Trends Genet. 17, 449-459.
39. WANG, A., and WANG, J.H. (1999). Effective treatment of murine leukemia with antisense poly-2′O-(2,4-dinitrophenyl)-oligoribonucleotides. Antisense Nucleic Acid Drug Dev. 9, 43-51.
40. WATERHOUSE, P.M., WANG, M.B., and LOUGH, T. (2001). Gene silencing as an adaptive defense against viruses. Nature 411, 834-842.
41. XIN, W., and WANG, J.H. (1998). Treatment of duck hepatitis B virus by antisense poly-2′-O-(2,4-dinitrophenyl)-oligoribonucleotides. Antisense Nucleic Acid Drug Dev. 8, 459-468.
42. ZHAO, H., DUPONT, J., YAKAR, S., KARAS, M., and LEROITH, D. (2004). PTEN inhibits cell proliferation and induces apoptosis by downregulating cell surface IGF-IR expression in prostate cancer cells. Oncogene 23, 786-794.